Literature DB >> 12789283

Gene-expression profiling in human cutaneous melanoma.

Kristen M Carr1, Michael Bittner, Jeffrey M Trent.   

Abstract

Genomic technology presents new and exciting opportunities to study complex human diseases. Several types of genomic analysis are helping to elucidate the biology of important human cancers. One of these, gene expression profiling, provides a more comprehensive view of the consequences of the genetic changes in cancer cells than was previously available. In addition to detailing the expression patterns of thousands of genes simultaneously, this exploding field of research has begun to build a new 'molecular taxonomy' of cancer and to identify novel disease genes for many human cancers, including cutaneous melanoma. Whether this new information will lead to improved treatments and prolonged survival for cancer patients remains to be determined. Here, we review the use of complementary DNA microarray technology to study gene expression patterns in cutaneous melanoma and highlight recent advances concerning the identification of novel melanoma disease-related genes. The fundamentals of microarray technology and analysis have been extensively discussed, and readers are referred to several recent reviews in this area.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12789283     DOI: 10.1038/sj.onc.1206448

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  Gene expression profiles of giant hairy naevi.

Authors:  M R K Dasu; R E Barrow; H K Hawkins; R L McCauley
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

Review 2.  [The role of molecular genetics in dermatologic diagnosis].

Authors:  M Braun-Falco; T Ruzicka
Journal:  Hautarzt       Date:  2012-04       Impact factor: 0.751

3.  AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma.

Authors:  Takeshi Namiki; Atsushi Tanemura; Julio C Valencia; Sergio G Coelho; Thierry Passeron; Masakazu Kawaguchi; Wilfred D Vieira; Masashi Ishikawa; Wataru Nishijima; Toshiyuki Izumo; Yasuhiko Kaneko; Ichiro Katayama; Yuji Yamaguchi; Lanlan Yin; Eric C Polley; Hongfang Liu; Yutaka Kawakami; Yoshinobu Eishi; Eishi Takahashi; Hiroo Yokozeki; Vincent J Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-01       Impact factor: 11.205

Review 4.  WNTS and WNT receptors as therapeutic tools and targets in human disease processes.

Authors:  Andy J Chien; Randall T Moon
Journal:  Front Biosci       Date:  2007-01-01

Review 5.  Rho/ROCK signaling in motility and metastasis of gastric cancer.

Authors:  Tasuku Matsuoka; Masakazu Yashiro
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 6.  A Wnt survival guide: from flies to human disease.

Authors:  Andy J Chien; William H Conrad; Randall T Moon
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

7.  Plasticity underlies tumor progression: role of Nodal signaling.

Authors:  Thomas M Bodenstine; Grace S Chandler; Richard E B Seftor; Elisabeth A Seftor; Mary J C Hendrix
Journal:  Cancer Metastasis Rev       Date:  2016-03       Impact factor: 9.264

8.  The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.

Authors:  Joseph Mazar; Katherine DeYoung; Divya Khaitan; Edward Meister; Alvin Almodovar; James Goydos; Animesh Ray; Ranjan J Perera
Journal:  PLoS One       Date:  2010-11-01       Impact factor: 3.240

Review 9.  Understanding signaling cascades in melanoma.

Authors:  Pablo Lopez-Bergami; Boris Fitchman; Ze'ev Ronai
Journal:  Photochem Photobiol       Date:  2007-12-15       Impact factor: 3.421

10.  Molecular changes induced by the curcumin analogue D6 in human melanoma cells.

Authors:  Carla Rozzo; Manuela Fanciulli; Cristina Fraumene; Antonio Corrias; Tiziana Cubeddu; Ilaria Sassu; Sara Cossu; Valentina Nieddu; Grazia Galleri; Emanuela Azara; Maria Antonietta Dettori; Davide Fabbri; Giuseppe Palmieri; Marina Pisano
Journal:  Mol Cancer       Date:  2013-05-04       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.